COVID-19: No deal yet to access “90% effective” vaccine tested in South Africa
The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.
